This study revealed that metformin, a commonly used oral drug for the treatment of type II diabetes, ameliorates diastolic LV chamber stiffness in mice with HFpEF-like symptoms by inducing a reduction in titin-based stiffness. Here, TTN is linked to type 2 diabetes mellitus.